Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

40.00
Delayed Data
As of Dec 13
 +1.85 / +4.85%
Today’s Change
22.25
Today|||52-Week Range
50.05
+58.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash33.0M36.4M34.2M66.4M
 
 
 
 
 
Short Term Investment Cash-7.3M3.4M-2.2M32.9M
 
 
 
 
 
Cash & Short Term Investments82.2M74.3M62.2M90.1M
 
 
 
 
 
 
ReceivablesReceivables5.5M17.3M25.9M41.5M
 
 
 
 
 
 
InventoriesInventories7.2M13.4M12.6M16.8M
 
 
 
 
 
 
Current AssetsOther Current Assets2.1M3.8M5.3M3.0M
 
 
 
 
 
Current Assets96.9M108.9M106.0M151.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross8.1M8.7M10.8M12.4M
 
 
 
 
 
Depreciation-5.6M-6.3M-7.0M-8.1M
 
 
 
 
 
Intangible Assets1.2M225.0K976.0K16.5M
 
 
 
 
 
Other Assets2.8M6.0M23.6M36.4M
 
 
 
 
 
Total Assets111.0M137.5M188.7M309.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.1M1.9M4.3M8.1M
 
 
 
 
 
Short Term Debt0.000.000.003.1M
 
 
Accrued Expenses9.5M19.1M43.8M60.2M
 
 
 
 
 
Other Current Liabilities18.2M19.8M44.3M60.4M
 
 
 
 
 
Other Liabilities26.4M27.5M56.1M80.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt34.4M26.9M7.2M31.5M
 
 
 
 
 
Deferred Taxes0.000.000.00-41.7M
 
 
Other Liabilities15.3M10.4M5.2M4.1M
 
 
 
 
 
Total Liabilities77.5M66.2M69.9M117.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity33.5M71.4M118.9M191.8M
 
 
 
 
 
Total Shareholder Equity33.5M71.4M118.9M191.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding40.0M43.0M49.0M50.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.